Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
Description
The development of novel optimized vaccines against coronavirus disease 2019 (COVID-19) that are capable of controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the appearance of different variants of concern (VoC
